Breaking News, Trials & Filings

Trials & Filings: Oct. 23, 2013

Lilly, Merck

Filings
FDA grants Lilly’s ramucirumab Priority Review… read more


Merck receives Breakthrough Designation for HCV drug… read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters